Nakamura, R <br/><br/>
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.  [electronic resource] 

 -  Bone marrow transplantation  Nov 2007 
 - 843-50 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1705801  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Graft Survival<br/>Graft vs Host Disease<br/>Hematologic Diseases--therapy<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Melphalan--therapeutic use<br/>Middle Aged<br/>Myelodysplastic Syndromes--complications<br/>Retrospective Studies<br/>Survival Analysis<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Vidarabine--analogs & derivatives